Wardwizard Healthcare closes trading window from July 1 till Q1FY27 results
Wardwizard Healthcare Ltd has closed its trading window from July 1, 2026, for designated persons until 48 hours after the Q1FY27 results are declared. The restriction is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The board meeting date for the results declaration is yet to be announced.

*this image is generated using AI for illustrative purposes only.
Wardwizard Healthcare Ltd has closed its trading window for all promoters, directors, and designated persons effective July 1, 2026. This measure is implemented to prevent insider trading ahead of the company's financial results announcement for the first quarter of the financial year 2026-27.
The trading window will remain shut until 48 hours after the declaration or publication of the unaudited standalone financial results for the quarter ended June 30, 2026. This closure covers all activities involving buying, selling, trading, pledging, or dealing in the company's securities.
The decision aligns with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct for regulating and monitoring trading by insiders. The code has been adopted to ensure compliance and prevent the misuse of unpublished price-sensitive information.
The company has not yet announced the specific date for its board meeting where the unaudited standalone financial results for the first quarter of FY27 will be declared. This date will be intimated to the stock exchanges in due course.
| Event | Date |
|---|---|
| Trading Window Closure | July 1, 2026 |
| Quarter End | June 30, 2026 |
| Financial Year | 2026-27 |
Historical Stock Returns for Wardwizard Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | 0.0% | 0.0% | +88.13% | +139.89% |
What market performance does Wardwizard anticipate for Q1 FY27 that necessitates such strict insider trading precautions?
How might the extended trading window closure impact liquidity and investor sentiment in the stock leading up to the results?
Will the upcoming board meeting include any strategic announcements beyond the unaudited financial results?

































